Congo Ebola outbreak passes 8,000 confirmed cases and 3,901 deaths, becoming country's deadliest ever

The Democratic Republic of the Congo has crossed a threshold no other Ebola outbreak in its history has reached. Confirmed cases of Ebola virus disease have passed 8,000, with government data released on Monday, September 28, 2026, showing 8,067 confirmed cases and 3,901 deaths as of September 26. The country's public health institute reported the figures, which make the current epidemic the largest and deadliest ever recorded in the DRC and the second-largest Ebola outbreak globally, after the 2014 to 2016 West Africa epidemic.

The outbreak is caused by the Bundibugyo virus, a rare species of the Ebola genus for which there is no approved vaccine and no approved treatment. The DRC announced the outbreak on May 15, 2026, and has struggled since to contain a pathogen that spreads through direct contact with the bodily fluids of infected people. Cases have now been recorded across 63 health zones in seven of the country's 26 provinces, a footprint that health officials describe as unusually wide for a single outbreak.

The case fatality rate stands at 48.4 percent, according to the latest government situation report, meaning that roughly one in every two people confirmed to have the virus has died. Of those infected, 2,070 patients have recovered, a figure that health officials say shows early supportive care can save lives even without a targeted therapy. The World Health Organization said in its latest report that the continuously high rate of deaths occurring in communities highlights the seriousness of the disease and the persistent challenges in timely case detection and access to early and adequate patient care.

The milestone arrived as international donors stepped forward with new money. On the sidelines of the United Nations General Assembly, the European Union announced a 7.5 million euro aid package to support the response to the Ebola crisis, and the United States announced the release of an additional 267 million dollars. Both pledges were reported as the outbreak surpassed the 8,000 case mark, and both were framed as part of a broader effort to shore up a response that has been losing ground.

Key Facts

The DRC's health ministry data showed 8,067 confirmed cases and 3,901 deaths as of September 26, 2026, across 63 health zones in seven of the country's 26 provinces. The fatality rate of more than 48 percent reflects a disease that kills roughly one in two people it infects. Xinhua reported on September 28 that the case fatality rate was 48.4 percent and that 2,070 patients had recovered.

Reuters reported on September 28 that confirmed cases had passed 8,000, citing government data released on Monday. The same report noted that the outbreak, caused by the Bundibugyo strain, has become the largest and deadliest in the DRC's history, and that there is currently no approved vaccine or treatment for the species.

The WHO said earlier in September that trials for three potential vaccines against the Bundibugyo strain should begin by October or November. The DRC, backed by WHO and Doctors Without Borders (MSF), also launched a test vaccination programme this month to see whether jabs designed for a different strain of the virus could prove effective in this case. The absence of an approved vaccine or treatment for the Bundibugyo species is what makes that trial timeline so consequential.

The Associated Press reported on September 28 that Congo was running out of health workers to contain the disease. According to the Africa Centres for Disease Control and Prevention, 50 health workers have died since the outbreak was announced. Health workers have complained about delayed or missing payments, triggering several strikes despite the delicate nature of the outbreak.

On Saturday, the European Union announced a 7.5 million euro aid package to support the response to the Ebola crisis. The European Commission said the funding would also help increase preparedness, response and health surveillance capacity in the long term, and that it forms part of a wider EU pledge of 710 million euros to support displaced people across Africa and provide global crisis relief. On Wednesday, the United States announced the release of an additional 267 million dollars to support the fight against the ongoing epidemic.

Analysis

The milestone matters for reasons that go beyond the arithmetic of case counts. What this really means is that an outbreak caused by a virus with no licensed countermeasures has now outrun every previous Congolese epidemic and is on a trajectory to rival the 2014 to 2016 West Africa outbreak, which killed 11,000 people. By week 19, that regional outbreak recorded 3,781 cases, while the current outbreak recorded 7,840, according to Africa CDC data. The WHO has said the current epidemic is on track to surpass the West African one.

Geographic expansion is now the defining feature of the response. Ituri Province remains the epicentre of the outbreak, but incidence there declined gradually from a mid-August peak. North Kivu Province saw a substantial rise that reached its highest reported level in mid-September, according to the WHO. Sustained transmission continues in Haut-Uele Province, and renewed transmission activity has been reported in Tshopo Province. Newly affected areas in Sud-Ubangi and Haut-Uele have increased the risk of cross-border transmission.

The human cost inside the response system is equally stark. Fifty health workers have died, and strikes over delayed or missing payments have interrupted care. Persuading underpaid staff to keep working in high-risk conditions is not an administrative detail; it is a core epidemiological variable. Every day a vaccination team does not go out, or a treatment centre does not open, is a day the virus gets to move through a population that has already been displaced, is already insecure, and is already hard to reach.

The bigger picture here is that the Bundibugyo species exposes a gap in the global stockpile system. Vaccines and treatments exist for the Zaire species, but not for this one. The WHO's plan to start trials for three candidate vaccines by October or November, and the test vaccination programme using jabs designed for a different strain, are attempts to close that gap in real time, under outbreak conditions, rather than in a laboratory. That is a harder and slower way to develop a countermeasure, but it is the only option available while the outbreak continues.

Why It Matters

The outbreak has already outpaced the West Africa epidemic at the same stage, and it is spreading through a region where insecurity, displacement and intense population movements complicate every public health intervention. The WHO has warned that the latest geographic expansion, including newly affected areas in Sud-Ubangi and Haut-Uele, increases the risk of cross-border transmission. A virus that crosses a border in a region with limited surveillance capacity becomes a problem for every country on the map, not just for the one that reports the cases.

The response also depends on money arriving in the right place at the right time. The EU's 7.5 million euro package and the US release of 267 million dollars are significant, and the EU funding is explicitly aimed at strengthening preparedness, response and health surveillance capacity in the long term. But they follow months in which health workers went unpaid. The gap between a pledge announced at the UN General Assembly and a salary paid to a contact tracer in North Kivu is the gap in which outbreaks grow.

Fifty dead health workers is a measure of what the response has already cost. It is also a warning about what happens when the people who run treatment centres and burial teams become casualties themselves. Outbreak control in this setting is not only a medical exercise. It is a test of whether the systems that deliver care can keep functioning while the disease spreads.

Next Up

The immediate test is the vaccination effort. The WHO said trials for three potential vaccines against the Bundibugyo strain should begin by October or November, and the DRC is already running a test programme with jabs designed for a different strain. Results will determine whether the response finally gets a tool that is specific to the virus it is fighting, rather than one borrowed from a different species.

In the meantime, health officials will be watching whether the decline in Ituri holds, whether North Kivu's rise continues, and whether the newly affected areas in Sud-Ubangi and Haut-Uele can be contained. The WHO's next situation reports will show whether the curve bends or keeps climbing toward the record set by West Africa a decade ago. With 8,067 confirmed cases and 3,901 deaths already recorded, the margin for error is close to zero.